Connect with us

coronavirus

Coronavirus: Commission supports blood services to increase COVID-19 convalescent plasma collection

SHARE:

Published

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

The Commission has selected 24 projects that will build new programmes, or expand existing ones, for the collection of plasma from donors recovered from COVID-19. The donations will be destined for the treatment of patients with the disease. These grants are the outcome of an invitation sent last July to all public and non-profit blood services around the EU, and in the UK, to apply for funding for the purchase of equipment for plasma collection. This action is financed through the Emergency Support Instrument, for a total of €36 million.

The projects, which will take place in 14 member states and the UK, are national or regional and will, in most cases, involve distribution of funds down to large numbers of local blood or plasma collection centres (over 150 in total). Health and Food Safety Commissioner Stella Kyriakides said:”When it comes to research on therapeutics for COVID-19, all options have to be explored to make sure that safe and effective treatments can be made available as quickly as possible. Thanks to the many applicants who have replied to the Commission's call, plasma collection can now be increased through the selected projects, which will help in the use of convalescent plasma as a possible promising treatment. We are doing everything possible to provide citizens with safe and effective therapeutics against COVID-19.”

A press release is available online.

Share this article:

EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter.

Trending